A share price of Vera Therapeutics Inc [VERA] is currently trading at $37.24, down -1.74%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VERA shares have gain 3.88% over the last week, with a monthly amount glided 5.83%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Vera Therapeutics Inc [NASDAQ: VERA] stock has seen the most recent analyst activity on January 25, 2024, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $26. On December 18, 2023, Raymond James initiated with a Outperform rating and assigned a price target of $29 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $26 on November 10, 2023. Guggenheim initiated its recommendation with a Buy and recommended $27 as its price target on August 16, 2023. Wedbush downgraded its rating to Neutral for this stock on January 04, 2023, and downed its price target to $8. In a note dated January 04, 2023, Jefferies downgraded an Hold rating on this stock and revised its target price from $32 to $6.
Vera Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $9.24 and $50.78. Currently, Wall Street analysts expect the stock to reach $26 within the next 12 months. Vera Therapeutics Inc [NASDAQ: VERA] shares were valued at $37.24 at the most recent close of the market. An investor can expect a potential drop of -30.18% based on the average VERA price forecast.
Analyzing the VERA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.48 and Total Capital is -0.31. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 36.36 points at the first support level, and at 35.48 for the second support level. However, for the 1st resistance point, the stock is sitting at 38.66, and for the 2nd resistance point, it is at 40.08.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Vera Therapeutics Inc [NASDAQ:VERA] is 21.15. In addition, the Quick Ratio stands at 21.15 and the Cash Ratio stands at 1.36.
Transactions by insiders
Recent insider trading involved MARSHALL FORDYCE, Director, that happened on Aug 14 ’24 when 15625.0 shares were purchased. SVP, FINANCE, CHIEF ACCT OFFCR, Young Joseph R completed a deal on May 16 ’24 to sell 20651.0 shares. Meanwhile, SVP, FINANCE, CHIEF ACCT OFFCR Young Joseph R sold 10186.0 shares on May 15 ’24.
